- ‘Uptime’ Participation Intervention in Girls and Women With Rett Syndrome
- A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
- A Safety Study of NNZ-2566 in Patients With Rett Syndrome
- A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)
- A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
- Advanced Grandparental Age as a Risk Factor for Autism
- An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
- An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
- An Open-label Extension Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
- Analysis of the Glutathione Cycle in Children With Rett Syndrome
- ANAVEX2-73 Study in Patients With Rett Syndrome
- ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome
- ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
- Biobanking of Rett Syndrome and Related Disorders
- Creatine Metabolism in Rett Syndrome
- Development of the ORCA Communication Measure for Rett Syndrome
- Effects of Creatine Supplementation in Rett Syndrome
- Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
- Functional Abilities in Rett Syndrome
- Gene Editing as a Therapeutic Approach for Rett Syndrome
- Genetic and Physical Characteristics of Rett Syndrome
- Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
- Intensive Anti-Scoliosis Postural Intervention for Individuals With Rett Syndrome Supported by a Smartphone Application
- Measuring Impact of Computer Gaming on Arm Use in Rett Syndrome
- Metabolic Evaluation of Nutrition in Rett Syndrome
- Natural History of Rett Syndrome & Related Disorders
- New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization
- Nutritional Aspects of Rett Syndrome
- Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.
- Open-Label Extension Study of Trofinetide for Rett Syndrome
- Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome
- Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
- Patients With RETT Syndrome
- Pharmacological Treatment of Rett Syndrome With Glatiramer Acetate (Copaxone)
- Pharmacological Treatment of Rett Syndrome With Statins
- Phase 2 Study of EPI-743 for Treatment of Rett Syndrome
- Pilot Study of the Effects of the Desipramine on the Neurovegetative Parameters of the Child With Rett Syndrome
- Placebo Controlled Trial of Dextromethorphan in Rett Syndrome
- Predictors of Caregiver Adaptation to Pervasive Developmental Disorders
- Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Xbiotics_RTT)
- Rett Syndrome Registry
- Safety and Efficacy of TSHA-102 in Adult Females With Rett Syndrome (REVEAL Adult Study)
- Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
- Study of ANAVEX2-73 in Patients With Rett Syndrome
- Study of Cardiac and Paroxysmal Abnormalities in Rett Syndrome
- Study of the Pathogenesis of Rett Syndrome
- Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
- Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients
- Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome
- Telehealth Support to Increase Physical Activity in Rett Syndrome
- The Findings of MR Imaging in Rett Syndrome
- The Rett Syndrome Global Registry
- The Role of Dietary Calcium for the Treatment of Osteopenia in Girls With Rett Syndrome
- The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett Syndrome
- Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome
- Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin
- Treatment of Rett Syndrome With Recombinant Human IGF-1
- Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)
- Trial of Dextromethorphan in Rett Syndrome
Clinical Trials
- Assessment of Long Acting Penicillin Use in Rheumatic Fever Patients
- Clinical Audit on the Managment in Assiut University Children Hospital
- Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes
- Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children
- Plasma Adiponectin Levels and Relations With Cytokines in Children With Acute Rheumatic Fever
- Rheumatic Heart Disease in Peru: Prevalence and Cardiovascular Outcomes Among Schoolchildren
- The Genetic Basis of Acquired Heart Disease in Africa
- A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies
- A Study of PRT2527 in Participants With Relapsed/Refractory Hematologic Malignancies
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Patients With Richter’s Syndrome;
- A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter’s Syndrome
- Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia
- Allogeneic Stem Cell Transplant for CLL
- ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
- Atezolizumab, Gemcitabine, Oxaliplatin, and Rituximab in Treating Patients With Relapsed or Refractory Transformed Diffuse Large B-Cell Lymphoma
- Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome
- Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma
- BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation
- CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
- CRC043: A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter’s Syndrome
- Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma
- Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
- Efficacy and Safety of Zanubrutinib Plus Tislelizumab for Treatment of Patients With Richter Transformation
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia
- Genomic and Proteomic Study of Richter Syndrome (CGPSR)
- Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation
- Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter’s Transformation
- Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation
- Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter`s Transformation Requiring Allogeneic Stem Cell Transplantation
- Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter’s Syndrome
- Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter’s Transformation and Leukemias
- Phase 1 Study VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
- PNT2258 for Treatment of Patients With Richter’s Transformation (Brighton)
- Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter’s Transformation
- R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL
- Registry of the German CLL Study Group
- Safety & Efficacy Study of Epcoritamab in Subjects With R/R Chronic Lymphocytic Leukemia and Richter’s Syndrome
- Selinexor in Initial or Refractory and/or Relapsed Richter’s Transformation
- Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter’s Transformation
- Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin’s Lymphomas
- Study of Blinatumomab in Richter Transformation
- Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma
- Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter’s Syndrome
- Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter’s Transformation or Richter’s Syndrome Patients
- Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter’s Transformation
- Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF
- Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)
- Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia
- Venetoclax in Combination With Ublituximab and Umbralisib (TGR-1202) in Patients With Relapsed or Refractory CLL/SLL
- Hypophosphatemic Rickets in Norway
- Maternal and Infant Vitamin Status During the First Nine Months of Infant Life
- Resistance to Vitamin D or Parathyroid Hormone
- Rickets Device – Feasibility Study
- Studies With 1,25-Dihydroxycholecalciferol
- Study to Assess the Use of a Simple Lab Test to Screen for Rickets in Children
- The Impact of Phosphate Metabolism on Healthy Aging
- Vitamin D Supplementation in Breastfeeding Women
- Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.
- Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
- Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome
- Penn Uterine Transplantation for Uterine Factor Infertility Trial
- Quality of Life in Vaginal Aplasia Patients After Davydov Procedure
- Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI)
- Uterus Transplantation From a Multi-organ Donor
- Uterus Transplantation From Live Donors and From Deceased Donors – Clinical Study
- Uterus Transplantation Procedure From a Live Donor
- A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)
- A Study of Cognitive-Behavioral Therapy for Rumination Disorder
- Placebo-controlled, Randomized Trial of a Simplified Biofeedback Technique for the Treatment of Rumination
- Treament of Rumination
- Treatment of Rumination by Biofeedback – a Randomized Controlled Trial
- A Long-term Follow-up Study of Patients With MPS IIIA Treated With ABO-102
- A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101
- A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome)
- A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
- A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
- A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
- A Treatment Extension Study of Mucopolysaccharidosis Type IIIB
- A Treatment Study of Mucopolysaccharidosis Type IIIB
- An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.
- Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
- Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type IIIA
- Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB
- Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease
- Intracerebral Gene Therapy for Sanfilippo Type A Syndrome
- Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome
- Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy
- Natural History Observational Study of MPS IIIa in SMC
- Natural History Studies of Mucopolysaccharidosis III
- Natural History Study of Patients With MPS IIIA
- Open-label Study of Anakinra in MPS III
- Parental Coping With Challenging Behavior in Mucopolysaccharidosis Type I-III
- Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
- Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
- Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
- Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients
- Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA)
- The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
- A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)
- A Clinical Study of Tranilast in the Treatment of Sarcoidosis
- A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)
- A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid
- A Phase 2 Study With CC-220 in Skin Sarcoidosis
- A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis
- A Study of Adalimumab to Treat Sarcoidosis of the Skin
- A Study of Infliximab in Patients With Sarcoidosis
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis
- A Suspected Association Between Sarcoidosis and Development of Diabetes Mellitus
- A Trial of EBUS-TBNA Versus Conventional TBNA in Diagnosis of Sarcoidosis
- A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy
- A Trial to Compare Two Methods of Obtaining Tissue for Diagnosis of Sarcoidosis Namely the Conventional Method or the Ultrasound Guided Method
- ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients
- ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
- ACTHAR Therapy for Central Nervous System Sarcoidosis
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
- An RCT of 19G EBUS-TBNA Needle in Suspected Sarcoidosis
- Association Between Cancer and Sarcoidosis
- Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) – LARIAT
- Benefit of Wearing an Activity Tracker in Sarcoidosis
- Bronchoscopic Sampling Techniques in Sarcoidosis
- Cardiac Sarcoidosis and FDG-PET
- Cardiac Sarcoidosis Randomized Trial
- Cardiac Sarcoidosis Response To Steroids Trial
- Cardiac Sarcoidosis: FDG PET vs. Ga-DOTANOC PET
- Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia
- Cell Free DNA in Cardiac Sarcoidosis
- Chronic Fatigue in Sarcoidosis
- Clinical and Genetic Study of Familial Sarcoidosis (SARCFAM)
- CNS Sarcoidosis and Acthar Gel
- Comparison of Characteristics of Bronchoalveolar Lavage Dusting and of Specific Questionnary Data in Healthy Volunteers and Patients Suffering From Sarcoidosis
- Comparison of Three Different Puncture Techniques in EBUS-TBNA
- Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies
- CryoSpray Ablation(tm)Thoracic Patient Registry
- Development of a Novel Human In Vitro Sarcoidosis Model
- Development of Airway Absorption Sampling Methods
- Development of the Danish Prospective Sarcoidosis Registry and Baseline Characteristics of a Danish Sarcoidosis Cohort
- Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)
- Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples
- Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis
- Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient
- Diffuse Fibrotic Lung Disease
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- EBUS vs EUS-B for Diagnosing Sarcoidosis
- EBUS-TBNA Versus EBUS-TBNB
- EBUS-TBNA vs Flex 19G EBUS-TBNA
- EBUS-TBNA vs Flex 19G EBUS-TBNA
- Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma
- Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis
- Efficacy of Antituberculous Therapy in Management of Sarcoidosis
- Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis
- Endobronchial Ultrasonography in the Diagnosis of Sarcoidosis
- Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
- Evaluating Airway Sarcoidosis Pathology With MRI
- Evaluation of MyoStrain™ in Clinical Practice
- Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
- Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
- Exercise Training in Sarcoidosis (EXTRAS Study)
- Exploring the Immunology of Sarcoidosis
- Fatigue and Exercise Training in Patients With Sarcoidosis
- Fatigue in Sarcoidosis – Treatment With Methylphenidate
- Fibrosing ILD Biomarkers That Rule Acceleration
- Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy
- Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
- Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis
- Genetic Epidemiology of Sarcoidosis
- Genomic Research in Sarcoidosis
- Hair Cortisol and Testosterone Levels in Patients With Sarcoidosis
- Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis
- High-definition Videobronchoscopiy in Sarcoidosis
- Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and Sarcoidosis
- Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis
- Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes
- Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension
- Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
- Inspiratory Muscle Training in Patients With Interstitial Lung Disease
- Inspiratory Muscle Training in Sarcoidosis
- Interstitial Lung Disease Research Unit Biobank
- Janus Kinase Inhibition in Sarcoidosis
- Labial Biopsy in Patients With Tuberculosis Disease
- Mayo AVC Registry and Biobank
- Minimally Invasive Techniques Or Surgery In the Diagnosis of Sarcoidosis
- Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)
- Muscle Strength and Exercise Capacity in Sarcoidosis Patients
- Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
- Neurosarcoidosis : Initial Presentation and Disease Course
- Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis
- Number of Multiple Breath Washout Tests in Adults With Pulmonary Disease and Healthy Controls
- Obstructive Sleep Apnoea in Sarcoidosis
- Optical Biopsy for Thoracic Lymph Nodes.
- Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82
- Patient Reported Outcome Instruments in Sarcoidosis
- Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis
- PET MRI Study in Patients With Cardiac Sarcoidosis
- PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC
- Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
- Physical Training in Sarcoidosis Patients
- Prevalence and Malignant Involvement of Intrathoracic Lymph Nodes in Patients Undergoing Endosonography
- Prevalence of Obstructive Sleep Apnea Syndrome in Sarcoidosis and Impact of CPAP Treatment on Associated Fatigue Status
- Radiographic Characteristics of Mediastinal and Hilar Lymph Nodes in Sarcoidosis
- Randomized Clinical Trial of Endobronchial Ultrasound Needle Aspiration With and Without Suction
- Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
- RCT Comparing 21 and 22 G Needle in the Diagnosis of Sarcoidosis by EBUS TBNA
- Registry for Advanced Sarcodiosis
- Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
- Rickettsial Genesis to Sarcoidosis in Denmark
- Riociguat for Sarcoidosis Associated Pulmonary Hypertension
- Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
- Role of Proteomics in Diagnosing Sarcoidosis
- Routine Cardiac Screening in Sarcoidosis Patients
- Salivary Proteins in Disease and Health
- Sarcoid Genetic Analysis (SAGA)
- Sarcoidosis and Immune Cells in Lung, Lymph Nodes and Blood
- SARCOTHAL. Thalidomide in Skin Sarcoidosis
- Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis
- Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
- SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
- Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.
- Study of Eye Tissue for Sarcoidosis
- Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis
- Test-retest Reliability for Fatigue Assessment Scale, Short Form 6 Dimension and King’s Sarcoidosis Questionnaire
- Testing Hypersensitivity to Metals in Sarcoidosis Patients by Applying the MELISA Test.
- The Effect of Quercetin in Sarcoidosis
- The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
- The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis
- The Lung Microbiome in Sarcoidosis
- the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis
- Trial of Adalimumab in Progressive Sarcoidosis
- Trial of Antimycobacterial Therapy in Sarcoidosis
- University of Virginia Natural History Study
- Use of Armodafinil for Fatigue in Sarcoidosis
- Use of CXCL9 as a Biomarker of Acthar Efficacy
- Use of Focalin for Fatigue in Sarcoidosis
- Use of Immunosuppressive Therapy for Sarcoidosis
- Validation of a Non-invasive Diagnostic Method for Sarcoidosis Using Exhaled Breath
- Validation of King’s Sarcoidosis Questionnaire in a Danish Population
- Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling
- Vitamin D Homeostasis in Sarcoidosis
- Worldwide Sarcoidosis Research Study
- A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis
- A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis
- Atorvastatin to Treat Pulmonary Sarcoidosis
- Azithromycin a Treatment for Pulmonary Sarcoidosis
- Effectiveness of Methotrexate Versus Prednisolone as First-line Therapy for Pulmonary Sarcoidosis
- Feasibility & Effect of a Tele-rehabilitation Program in Pulmonary Sarcoidosis Pulmonary Sarcoidosis
- The Role of Physical Activity and Diet Within Pulmonary Sarcoidosis
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis